---
title: "ARCH Venture Fund XIV Reports Acquisition of $18 Million in Aspen Neuroscience Common Shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304042044.md"
description: "ARCH Venture Partners XIV acquired 1,200,000 common shares of Aspen Neuroscience at $15 per share, totaling $18 million. This transaction was reported in a beneficial ownership filing with the SEC on November 2, 2026. Following the purchase, ARCH's total beneficial ownership in Aspen Neuroscience stands at 1,200,000 shares."
datetime: "2026-11-03T02:47:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304042044.md)
  - [en](https://longbridge.com/en/news/304042044.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304042044.md)
generator: "portal-rs"
---

# ARCH Venture Fund XIV Reports Acquisition of $18 Million in Aspen Neuroscience Common Shares

-   ARCH Venture Partners XIV reported purchasing 1,200,000 Aspen Neuroscience common shares at $15 each in a beneficial ownership filing. \* Reported beneficial ownership following the purchase totaled 1,200,000 common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-444141), on November 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ASPE.US](https://longbridge.com/en/quote/ASPE.US.md)

## Related News & Research

- [ARCH Venture Partners X Discloses 12.9% Stake in Aspen Neuroscience](https://longbridge.com/en/news/304929595.md)
- [Aspen Neuroscience's Amended Bylaws Take Effect at IPO Closing](https://longbridge.com/en/news/304014788.md)
- [OrbiMed Advisors reports acquisition of $15 million in Aspen Neuroscience common shares](https://longbridge.com/en/news/304354913.md)
- [OrbiMed Advisors Discloses Investment at Aspen Neuroscience, Inc. with 12.3% Stake](https://longbridge.com/en/news/304700413.md)
- [Jim Cramer says Nvidia’s leadership shake-up won’t derail the AI trade](https://longbridge.com/en/news/305736094.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**